In this article, we will thoroughly explore TRIMU 5 and its relevance in the current context. Since its emergence, TRIMU 5 has caught the attention of many people due to its impact in different spheres. Over the years, TRIMU 5 has evolved and adapted to the changing needs of society, becoming a topic of constant interest. Through this research, we seek to expand the understanding of TRIMU 5 and its influence in various areas, as well as analyze its role in the present and future. By exploring multiple perspectives and reliable sources, it is hoped to provide a comprehensive and enriching view on TRIMU 5 and its importance today.
| Names | |
|---|---|
| IUPAC name
L-Tyrosyl-N-{acetyl}-D-alaninamide
| |
| Systematic IUPAC name
(2R)-2-Amino-3-(4-hydroxyphenyl)-N-acetamido}-1-oxopropan-2-yl]propanamide | |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C19H30N4O4 | |
| Molar mass | 378.466 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
| |
TRIMU-5 is a selective agonist of the μ2-opioid receptor and antagonist of the μ1-opioid receptor.[1][2] It produces analgesia in animals that differs from that of conventional μ-opioid receptor agonists but that can still be blocked by μ-opioid receptor antagonists.[1] TRIMU-5 can also block the analgesic effects of μ-opioid receptor agonists like morphine.[1] In addition to analgesia, TRIMU-5 inhibits gastrointestinal transit, a known effect of μ2-opioid receptor activation.[1]